Cigna Corp (CI)
$162.45 1.57 (0.98%)
18:59 EDT CI Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 39.52B
PE Ratio 15.94
Volume (Avg. Vol.) 1.85M
Day's Range 159.00 - 162.71
52-Week Range 118.50 - 224.64
Dividend & Yield 0.04 (0.02%)
CI Stock Predictions, Articles, and Cigna Corp News
- From InvestorPlace
- From the Web
Analysts are telling investors to buy Cigna stock, but there are reasons to question the long-term future of the health insurer.
As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.
Friday's big stock charts feature names that have struggled but could now be in the buy zone.
When considering these seven companies in 2020, should insider buying be one of your deciding factors? The answer just might be yes.
Tesla ripped to new highs and Nike's been named a Top Pick. Here's what else happened in the stock market today.
The doctor is ordering you to protect your portfolio by avoiding these seven healthcare stocks. There are better investments elsewhere.
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
Cigna, Bed Bath & Beyond, Micron and Canopy Growth were our top stock trades on Thursday as we go into Friday.
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
These healthcare stocks have each hit a rough road for various reasons. Here's what investors need to know about each.
Cigna earnings for the fourth quarter of the year included poor 2019 guidance, sending CI stock falling on Friday.
It’s time to get defensive. Nasdaq has now confirmed's in a bear market. Here are 7 'Strong Buy' defensive stocks to buy now.
Edison, NJ -- (SBWIRE) -- 09/24/2020 -- Global Smokeless Tobacco Treatment Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Smokeless Tobacco Treatment Market. Some of the key players profiled in the study are Pfizer Inc. (United States), GlaxoSmithKline plc. (United Kingdom), Johnson & Johnson Services Inc. (United States), Novartis (Switzerland), Cigna (United States), Yesmoke (Italy), Habitrol (New Zealand), Perrigo Co. Plc. (Ireland) and Cambrex Corporation (United States).
From Market News Video
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..
From Talk Markets
Navellier RatingsPowered by Portfolio Grader